Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-0.72	85.38	86.00
Graham Fair Price	3.00	46.78	45.41
PEG	172.73	7.04	2.58
Price/Book	-4.38	4.37	4.57
Price/Cash Flow	-48.80	42.88	83.74
Prices/Earnings	-9.75	42.54	47.14
Price/Sales	-2.71	28.56	29.36
Price/FCF	-48.80	42.88	83.74
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.29	0.68	0.69
Operating Margin	-2.73	0.19	0.19
ROA	13.32	0.02	0.01
ROE	0.02	0.03	5.95
ROIC	0.02	0.02	-10.66
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	0.07	-81.25
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.20	-0.04	-77.81
EPS QOQ	0.18	0.06	-66.91
FCF QOQ	1.38	0.87	-37.23
Revenue QOQ	0.07	-0.02	-74.50
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	110.61	42.11	-61.93
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.15	0.15	-0.28
Quick Ratio	0.96	0.95	-1.42
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	61.49	61.53	0.06
Cash	14.63	18.22	24.49
Capex	-0.15	-0.17	-10.88
Free Cash Flow	3.36	6.27	86.86
Revenue	9.57	9.42	-1.66
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.02	1.03	0.52
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.98	1.58	-20.22
Naive Interpretation	Member

06 - Financial Health · Bad

Rating